3-acetylpyridine has been researched along with varenicline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antilla, JC; Bickford, PC; Engberg, ME; Hudson, CE; Kang, CW; Lambert, CS; Philpot, RM; Rowell, PP; Wecker, L; Zesiewicz, TA | 1 |
| Engberg, ME; Johns, BE; Lambert, CS; Philpot, RM; Wecker, L | 1 |
2 other study(ies) available for 3-acetylpyridine and varenicline
| Article | Year |
|---|---|
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Topics: Animals; Ataxia; Benzazepines; Cerebellum; Dose-Response Relationship, Drug; Gait; Male; Mecamylamine; Motor Activity; Nerve Degeneration; Neural Pathways; Niacinamide; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Olivary Nucleus; Postural Balance; Pyridines; Quinoxalines; Rats; Rotarod Performance Test; Varenicline | 2013 |
Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.
Topics: Animals; Ataxia; Biomechanical Phenomena; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Gait; Male; Niacinamide; Nicotinic Agonists; Olivary Nucleus; Principal Component Analysis; Pyridines; Random Allocation; Rats, Sprague-Dawley; Varenicline; Walking | 2015 |